Home » News » IBD Educational Lectures, presented by The McGill IBD Research Group

IBD Educational Lectures, presented by The McGill IBD Research Group

Thursday, April 12, 2018, 7:30pm at the Research Institute of the MUHC Amphitheatre | E Block

Manipulating the Microbiome in IBD – The Cause? The Solution? Both? Neither?
Charles N. Bernstein MD, FRCP
Director, University of Manitoba IBD Clinical and Research Centre
Winnipeg, MB

Dr. Charles Bernstein gastroenterologistCharles N. Bernstein, a graduate from the University of Manitoba Faculty of Medicine, and the UCLA Division of Gastroenterology Fellowship Training Program is Distinguished Professor of Medicine, Bingham Chair in Gastroenterology Research; Head – Section of Gastroenterology, and Director, Inflammatory Bowel Disease Clinical and Research Centre at the University of Manitoba. Dr Bernstein has developed among the largest validated population based databases of IBD. His main research interests are primarily related to IBD; in terms of optimizing management approaches; exploring predictors of clinical outcomes; and disease etiology. More recently he has been actively involved in exploring the biological and clinical intersection between different chronic immune mediated inflammatory diseases.

Personalized Medicine in IBD: Are we there yet?
Marla Dubinsky, MD
Professor of Pediatrics
Co-director, Susan and Leonard Feinstein IBD Center
Icahn School of Medicine, Mount Sinai NY

Dr. Marla Dubinsky gastroenterologistMarla C. Dubinsky received a medical degree from Queen’s University in Canada and completed her clinical pediatric gastroenterology training at Sainte-Justine Hospital, University of Montreal in Quebec, Canada. Currently, Dr. Dubinsky is Chief of Pediatric Gastroenterology, Hepatology and Nutrition, as well as Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai Hospital in New York. Dr. Dubinsky’s main research interests are the influence of genetics and immune responses on the variability in clinical presentations of early-onset IBD and prognosis.

Previous educational sessions
Fecal Microbiota Transplantation: The Ultimate Probiotic
This presentation was given by Marco A. Bergevin, MD, FRCPC, Medical Microbiologist and Infectious Disease Specialist, who spoke about Fecal Microbiota Transplantation: The Ultimate Probiotic.
To view the presentation, click the link to download: FMT- ultimate probiotic